28 February 2020
Visiongain has launched a new pharma report Global Bioprocess Optimisation & Digital Biomanufacturing Market Forecast to 2029.
The Global market for bioprocess optimisation and digital biomanufacturing is favoured by the increasing global population which by 2050 will be predominately 65 years and above. There is also a growing demand for biologics drugs and biosimilar drugs which has compelled manufacturers to introduce technologies that would help bring the drugs to the market at a far more rapid pace than before.
The lead analyst of the report commented "The Bioprocess Optimization and Digital Manufacturing market is expected to witness a robust growth during the years of forecast owing to rise in biosimilars, growing complexity of drug manufacturing and patent expiry of blockbuster drugs coupled with rising cost containment pressure on biopharmaceutical players which is also expected to improve the uptake of digitally advanced products for manufacturing. With respect to the technology market, the analytical and process control technologies are expected to witness the highest growth during the forecast period. The bioreactors market is expected to foresee the highest growth during the forecast period."
Leading companies featured in the report include ABB, 3M Co., Danaher Corporation, Agilent Technologies, Applikon Technology, Sartorius Stedium Biotech, Shimadzu Corp., Siemens Healthcare and many others.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
03 July 2020
Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
03 July 2020
With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.
01 July 2020
The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.